Reclassifying insulins

Michael D. Feher; Clifford J. Bailey

doi:10.1177/14746514040040010701

Reclassifying insulins

Michael D. Feher^*
, Clifford J. Bailey

^*Corresponding author for this work

College of Health and Life Sciences

Beta Cell Diabetes Centre
Chelsea/Westminster Hospital

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

Insulins have hitherto been distinguished as clear (short-acting) and cloudy (long-acting). However the introduction of glargine, which is clear long-acting insulin, has prompted the need for reclassification. In view of the increasing emphasis on intensive insulin therapy using basal-regimens, a new, simple, pragmatic classification is suggested in which insulin are categorised according to the timing and purpose of administration: basal (maintenance), bolus (meal) and biphasic (mixed).

Original language	English
Pages (from-to)	39-42
Number of pages	4
Journal	British Journal of Diabetes and Vascular Disease
Volume	4
Issue number	1
DOIs	https://doi.org/10.1177/14746514040040010701
Publication status	Published - 1 Jan 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Basal insulins
Biphasic insulins
Bolus insulins
Insulin

Access to Document

10.1177/14746514040040010701

Cite this

@article{2e3b2100bbd746f7a397a8113cb466e2,

title = "Reclassifying insulins",

abstract = "Insulins have hitherto been distinguished as clear (short-acting) and cloudy (long-acting). However the introduction of glargine, which is clear long-acting insulin, has prompted the need for reclassification. In view of the increasing emphasis on intensive insulin therapy using basal-regimens, a new, simple, pragmatic classification is suggested in which insulin are categorised according to the timing and purpose of administration: basal (maintenance), bolus (meal) and biphasic (mixed).",

keywords = "Basal insulins, Biphasic insulins, Bolus insulins, Insulin",

author = "Feher, \{Michael D.\} and Bailey, \{Clifford J.\}",

year = "2004",

month = jan,

day = "1",

doi = "10.1177/14746514040040010701",

language = "English",

volume = "4",

pages = "39--42",

journal = "British Journal of Diabetes and Vascular Disease",

issn = "1474-6514",

publisher = "SAGE",

number = "1",

}

TY - JOUR

T1 - Reclassifying insulins

AU - Feher, Michael D.

AU - Bailey, Clifford J.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Insulins have hitherto been distinguished as clear (short-acting) and cloudy (long-acting). However the introduction of glargine, which is clear long-acting insulin, has prompted the need for reclassification. In view of the increasing emphasis on intensive insulin therapy using basal-regimens, a new, simple, pragmatic classification is suggested in which insulin are categorised according to the timing and purpose of administration: basal (maintenance), bolus (meal) and biphasic (mixed).

AB - Insulins have hitherto been distinguished as clear (short-acting) and cloudy (long-acting). However the introduction of glargine, which is clear long-acting insulin, has prompted the need for reclassification. In view of the increasing emphasis on intensive insulin therapy using basal-regimens, a new, simple, pragmatic classification is suggested in which insulin are categorised according to the timing and purpose of administration: basal (maintenance), bolus (meal) and biphasic (mixed).

KW - Basal insulins

KW - Biphasic insulins

KW - Bolus insulins

KW - Insulin

UR - https://www.scopus.com/pages/publications/1542360024

UR - https://journals.sagepub.com/doi/pdf/10.1177/14746514040040010701

U2 - 10.1177/14746514040040010701

DO - 10.1177/14746514040040010701

M3 - Article

AN - SCOPUS:1542360024

SN - 1474-6514

VL - 4

SP - 39

EP - 42

JO - British Journal of Diabetes and Vascular Disease

JF - British Journal of Diabetes and Vascular Disease

IS - 1

ER -

Reclassifying insulins

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this